On Monday, Piper Sandler maintained its Overweight rating and $110.00 stock price target for Merit Medical Systems , Inc. (NASDAQ:MMSI), following the presentation of favorable clinical trial results.
Wells Fargo adjusted its outlook on Merit Medical Systems , Inc. (NASDAQ:MMSI) by increasing the price target to $103 from the previous $85, while maintaining an Equal Weight rating on the stock.
On Monday, Piper Sandler maintained its Overweight rating and $110.00 stock price target for Merit Medical Systems , Inc. (NASDAQ:MMSI), following the presentation of favorable clinical trial results.
In the lab, the team attempted to target BCL2. They found the best anti ... and Honorary Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust said, "We urgently need new ...
Wells Fargo (NYSE:WFC) adjusted its outlook on Merit Medical Systems , Inc. (NASDAQ:MMSI) by increasing the price target to $103 from the previous $85, while maintaining an Equal Weight rating on the ...